Finvest
EMR Industrial automation · Industrial tech · Automation · Dividend payer · Thesis updated June 12, 2026

Automation leader, uneven demand

01 Running thesis

A good business with a choppy map

Emerson is now mostly an automation company. It sells the controls, sensors, valves, test gear, and software that help big industrial sites run safely and efficiently. That gives it exposure to long projects in power, LNG, life sciences, chemicals, semiconductors, aerospace, and defense.

The bull case is that the new Emerson can grow at better margins than the old one. Management held its adjusted EPS guide at $6.45 to $6.55 even after cutting the sales view to about 3% underlying growth. That says cost control, pricing, and mix are still doing real work.

The bear case is that growth is not broad. Q2 2026 underlying sales rose only 0.5%. The U.S. was up 9%, but Europe was down 4%, AMEA was down 5%, and China was down 9%. Middle East conflict also became a new problem, costing 1 point of Q2 underlying sales and expected to cost 1 point for the full year.

This is why the setup looks balanced. Emerson has better assets than it used to have, and Test & Measurement is improving fast. But the company now needs a second-half sales pickup while China is weak and a key region is disrupted.

May 2026▼Q2 2026 added a new Middle East risk. Management said the conflict caused a 1 point hit to Q2 underlying sales and should reduce full-year underlying sales by 1 point.
May 2026▼China weakened further, with Q2 underlying sales down 9%. Management now expects China to fall mid-single digits for the year, mainly because chemical industry spending remains weak.
May 2026→Despite lower sales guidance, management kept adjusted EPS guidance at $6.45 to $6.55. The thesis now depends more on margin execution and second-half improvement.
Feb 2026▲Q1 2026 orders rose 9%, helped by North America, power, LNG, India, and Middle East and Africa demand before the later conflict disruption. This improved visibility into the second half.
Feb 2026→Emerson changed its reporting structure to five segments: Control Systems & Software, Test & Measurement, Sensors, Final Control, and Safety & Productivity.
Nov 2025▲The fiscal 2025 10-K confirmed AspenTech was fully acquired and integrated. Control Systems & Software adjusted EBITA margin reached 31.0% for fiscal 2025.
Nov 2025▲Management said Emerson had completed its transformation into a more focused automation company. Test & Measurement orders surged 27% in Q4 2025, showing a turn in that business.
Aug 2025▲The AspenTech acquisition closed, removing a major portfolio execution risk. Fiscal Q3 2025 underlying sales grew 3%, with early improvement in weaker automation markets.
02 Business model

Automation parts, software, and service

Emerson makes money by selling industrial equipment and software that customers often keep using for years. A refinery, power plant, water system, drug factory, or semiconductor lab may buy control systems, sensors, valves, test platforms, software licenses, upgrades, and services from Emerson.

The model can be attractive because many projects are large and hard to switch once installed. Software like AspenTech and control platforms like DeltaV and Ovation can also bring higher-margin revenue than basic hardware.

The weak point is timing. Big industrial projects can slip. Software renewals can move between quarters. Q2 showed both issues clearly, with software renewal timing hurting Software & Systems and the Middle East conflict disrupting Intelligent Devices.

Emerson is also reviewing Safety & Productivity. A sale or spin could make the portfolio cleaner, but the value and timing are still open questions.

03 Product portfolio

What Emerson sells

Cash cow

Control Systems & Software

This includes DeltaV, Ovation, and AspenTech software. Q2 2026 underlying sales fell 2% because some software renewals did not land in the quarter.

Growth engine

Test & Measurement

This is the former National Instruments business. Q2 2026 underlying sales rose 12%, led by aerospace, defense, and semiconductor demand.

Steady

Sensors

Sensors measure pressure, flow, temperature, and other data inside industrial systems. Q2 2026 underlying sales were flat.

Steady

Final Control

Final Control sells valves, actuators, and regulators that control the flow of liquids and gases. Q2 2026 underlying sales fell 1%, with Middle East disruption partly offset by power and LNG strength in the Americas.

Option

Safety & Productivity

This segment sells tools and equipment for professional users. Q2 2026 underlying sales rose 2%, and Emerson is still reviewing strategic options for the business.

04 Business segments

Q2 mix by segment

Control Systems & Software24%declining
Test & Measurement9%growing fast
Sensors22%flat
Final Control33%declining
Safety & Productivity12%modest

Segment mix uses fiscal Q2 2026 sales from Emerson's Form 10-Q. Intelligent Devices is still the largest group, so weakness in valves, sensors, or process spending can move the whole company.

05 Risk factors

What could go wrong

Middle East conflict disruption

High impact · Medium odds

Management said the conflict caused a 1 point hit to Q2 underlying sales and is expected to hurt full-year 2026 underlying sales by 1 point. Emerson has a $1.2 billion business in the region. A $100 million rebuild opportunity may help later, but the near-term effect is negative.

We watchListen for any change to the 1 point full-year sales drag and updates on project access, shipments, and the $100 million rebuild opportunity.

China keeps getting worse

Medium impact · Medium odds

China underlying sales fell 9% in Q2 2026. Management now expects China to be down mid-single digits for the year, worse than the earlier low-single-digit decline view. The main pressure is weak chemical industry spending, but the risk is that weakness spreads to other end markets.

We watchTrack China underlying sales, chemical-sector orders, and any new comments on weakness outside chemicals.

Second-half ramp misses

High impact · Medium odds

Full-year underlying sales are expected to rise about 3%, but Q2 growth was only 0.5%. That means the back half has to improve. If large projects slip or customers pause spending, the EPS guide may depend too much on cost control.

We watchCompare Q3 underlying sales and orders with the full-year 3% underlying growth target.

Software renewal timing

Medium impact · Medium odds

Control Systems & Software was hurt by renewal timing in Q2, and Software & Systems adjusted EBITA margin fell 2.5 percentage points. These renewals can make quarterly results look lumpy even when the long-term software base is healthy.

We watchWatch Control Systems & Software underlying sales and whether delayed renewals show up in later quarters.

Strategic review disappoints

Medium impact · Low odds

Safety & Productivity is under strategic review. A good sale or spin could sharpen Emerson's focus and free up capital. A weak price, long delay, or no deal would leave one more moving part in the story.

We watchLook for management's update on the Safety & Productivity review, including structure, timing, and use of proceeds.
06 Quick answers

In one breath

What does Emerson Electric do?

Emerson sells automation hardware, software, and services for industrial customers. Its products help plants, utilities, factories, and labs measure, control, test, and improve complex systems.

Why did Emerson lower its 2026 sales outlook?

Management pointed to Middle East conflict as a new drag and said it expects a 1 point hit to full-year underlying sales. China also worsened, with management now expecting a mid-single-digit decline for the year.

What is Emerson's fastest-growing business right now?

Test & Measurement is the standout. In Q2 2026, underlying sales rose 12%, and management raised its full-year growth outlook for that segment to low-teens.

Is Emerson more hardware or software?

It is both, but the company has moved toward a higher software mix through AspenTech and its control systems platforms. Hardware like sensors and valves still makes up a large part of sales.